Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGlaukos Corporation
About this trial
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Eligibility criteria
Qualifiers
Diagnosis of Open-angle glaucoma
18 years of age or older
Disqualifiers
Subject who is breast-feeding or pregnant
Trial design
Treatments tested in this trial
- Travoprost
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov